Zacks Investment ResearchThu, 11 Jun 2026 15:51:08 GMTHROW Stock Rises on Relaunch of Ophthalmology Drug Verkazia in the USHROW-2.44%
Seeking AlphaTue, 12 May 2026 18:30:51 GMTHarrow, Inc. (HROW) Q1 2026 Earnings Call TranscriptHROW-2.44%
Zacks Investment ResearchMon, 11 May 2026 23:06:19 GMTHarrow (HROW) Reports Q1 Loss, Lags Revenue EstimatesHROW-2.44%
Zacks Investment ResearchMon, 04 May 2026 15:00:28 GMTAnalysts Estimate Harrow (HROW) to Report a Decline in Earnings: What to Look Out forHROW-2.44%
Seeking AlphaTue, 14 Apr 2026 09:33:55 GMTHarrow: Probably A Short-Term Market OverreactionHROW-2.44%
